Search Results - "Alessandro, Cappetta"
-
1
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma
Published in Scientific reports (05-11-2022)“…IDH1 -mutated cholangiocarcinomas (CCAs) are an interesting group of neoplasia with particular behavior and therapeutic implications. The aim of the present…”
Get full text
Journal Article -
2
Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies
Published in Critical reviews in oncology/hematology (01-01-2012)“…Abstract Despite recent improvements in surgical techniques and chemotherapy treatments, locally advanced/metastatic gastroesophageal junction (GEJ) and…”
Get full text
Journal Article -
3
Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy
Published in Biomedicines (30-04-2022)“…Novel targeted therapies for metastatic colorectal cancer are needed to personalize treatments by guiding specific biomarkers selected on the genetic profile…”
Get full text
Journal Article -
4
Neoplastic Meningitis from Solid Tumors: New Diagnostic and Therapeutic Approaches
Published in The oncologist (Dayton, Ohio) (01-08-2011)“…Learning Objectives After completing this course, the reader will be able to: Compare the use of i.t. therapy and systemic therapies for patients with…”
Get full text
Journal Article -
5
Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer
Published in Anticancer research (01-09-2010)“…This was a phase II study to assess the activity of a novel neoadjuvant regimen in locally-advanced breast cancer. Fifty patients with histological…”
Get full text
Journal Article -
6
Hepatoid Adenocarcinoma of the Colon: What Should We Target?
Published in Pathology oncology research (01-01-2012)Get full text
Journal Article -
7
A nurse-led telephone triage for the prevention and control of COVID-19 spread in an oncology department
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e13617 Background: After the results of the Nurse-led Telephone Triage (NTT) study ( Calvetti L, et al. ASCO 2020), the system has been…”
Get full text
Journal Article -
8
Negative hyperselection and mechanisms of acquired resistance to first-line chemotherapy plus anti-EGFR in patients (pts) with pMMR RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): A translational analysis of the TRIPLETE trial
Published in Journal of clinical oncology (01-06-2024)“…3572 Background: Anti-EGFRs plus doublets are the standard first-line treatment for patients with left-sided RAS/BRAFwt mCRC. Anti-EGFR sensitivity seems…”
Get full text
Journal Article -
9
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine
Published in Journal of chemotherapy (Florence) (17-11-2023)“…The phase III MPACT trial demonstrated the superiority of gemcitabine plus nab-paclitaxel (NABGEM) versus gemcitabine alone in previously untreated patients…”
Get full text
Journal Article -
10
Implementation of a MSRE ddPCR method for the detection of methylated WIF1 and NPY genes in colorectal cancer patients
Published in Tumori (01-10-2024)“…Background: Colorectal cancer is a worldwide leading cause of death accounting for high-rate mortality. Mutations in the epidermal growth factor receptor and…”
Get full text
Journal Article -
11
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters
Published in European journal of cancer (1990) (01-11-2022)“…IDH1-mutated intrahepatic cholangiocarcinomas (IDH1m iCCAs) could be treated with anti-IDH1 drugs, although the high heterogeneity in this class of tumours…”
Get full text
Journal Article -
12
From bench to bedside and back: prognostic groups of Phase 2 study of second-line FOLFIRI-aflibercept in prospectively stratified, RAS wild type, anti-EGFR resistant, metastatic colorectal cancer patients: The DISTINCTIVE trial—A GISCAD study
Published in Journal of clinical oncology (01-06-2022)“…e15571 Background: Currently, no validated biomarkers are available for second-line anti-angiogenic treatment in RAS wild type (wt) metastatic colorectal…”
Get full text
Journal Article -
13
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma
Published in European journal of cancer (1990) (01-08-2022)“…Background and Aims: Biliary tract cancers are rare malignancies with a poor prognosis and scarce therapeutic strategies. The significance of BRCAness in this…”
Get full text
Journal Article -
14
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study
Published in Journal of cancer research and clinical oncology (01-08-2023)“…Background FLOT regimen is the standard perioperative treatment in Western countries for patients with locally advanced gastric (GC) or gastroesophageal…”
Get full text
Journal Article -
15
FOLFOXIRI plus bevacizumab and atezolizumab as upfront treatment of unresectable metastatic colorectal cancer (mCRC): Updated and overall survival results of the phase II randomized AtezoTRIBE study
Published in Journal of clinical oncology (01-06-2023)“…3500 Background: AtezoTRIBE (NCT03721653) is a phase II randomized trial in which unresectable mCRC pts were randomized 1:2 to 1 st -line FOLFOXIRI/bev [arm A]…”
Get full text
Journal Article -
16
Platinum sensitivity in patients with IDH1/2 mutated vs wild‐type intrahepatic cholangiocarcinoma: A propensity score‐based study
Published in International journal of cancer (15-10-2022)“…Isocitrate dehydrogenase (IDH)1/2 mutations are the most frequent druggable alterations in intrahepatic cholangiocarcinoma (iCCA), reported in ~20% of cases…”
Get full text
Journal Article -
17
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241]
Published in European journal of cancer (1990) (01-12-2022)Get full text
Journal Article -
18
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and Clinical Outcomes in MSI-H population: The PROSECCO Study
Published in Journal of clinical oncology (01-06-2022)“…e16068 Background: The FLOT4-AIO phase II/III trial established perioperative FLOT regimen as the new standard in Western countries for patients (pts) with…”
Get full text
Journal Article -
19
The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
20